Immunodominant T cell peptides from four candidate malarial antigens as biomarkers of protective immunity against malaria.

[1]  F. Zavala.  RTS,S: the first malaria vaccine , 2022, The Journal of clinical investigation.

[2]  L. Amoah,et al.  Towards large-scale identification of HLA-restricted T cell epitopes from four vaccine candidate antigens in a malaria endemic community in Ghana. , 2021, Vaccine.

[3]  B. Peters,et al.  Comparative analysis of the ex vivo IFN-gamma responses to CD8+ T cell epitopes within allelic forms of PfAMA1 in subjects with natural exposure to malaria , 2021, PloS one.

[4]  B. Peters,et al.  Comparison of the impact of allelic polymorphisms in PfAMA1 on the induction of T Cell responses in high and low malaria endemic communities in Ghana , 2021, Malaria journal.

[5]  O. Traoré,et al.  Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial , 2021, The Lancet.

[6]  Bjoern Peters,et al.  Identification of Plasmodium falciparum circumsporozoite protein-specific CD8+ T cell epitopes in a malaria exposed population , 2020, PloS one.

[7]  M. Laurens.  RTS,S/AS01 vaccine (Mosquirix™): an overview , 2019, Human vaccines & immunotherapeutics.

[8]  Morten Nielsen,et al.  IEDB-AR: immune epitope database—analysis resource in 2019 , 2019, Nucleic Acids Res..

[9]  P. Sinnis,et al.  Alpha-v–containing integrins are host receptors for the Plasmodium falciparum sporozoite surface protein, TRAP , 2018, Proceedings of the National Academy of Sciences.

[10]  Bhartendu Nath Mishra,et al.  Genome-wide identification of novel vaccine candidates for Plasmodium falciparum malaria using integrative bioinformatics approaches , 2017, 3 Biotech.

[11]  Sumana Chakravarty,et al.  Sterile protection against human malaria by chemoattenuated PfSPZ vaccine , 2017, Nature.

[12]  Juliana K. Wambua,et al.  Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children. , 2016, The New England journal of medicine.

[13]  Mario Roederer,et al.  Protection against malaria at 1 year and immune correlates following PfSPZ vaccination , 2016, Nature Medicine.

[14]  M. Nielsen,et al.  The Length Distribution of Class I–Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele–Specific Binding Preference , 2016, The Journal of Immunology.

[15]  D. Drew,et al.  Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria , 2016, FEMS microbiology reviews.

[16]  Bjoern Peters,et al.  Measurement of ex vivo ELISpot interferon-gamma recall responses to Plasmodium falciparum AMA1 and CSP in Ghanaian adults with natural exposure to malaria , 2016, Malaria Journal.

[17]  D. Kaslow,et al.  RTS,S: Toward a first landmark on the Malaria Vaccine Technology Roadmap. , 2015, Vaccine.

[18]  M. Medina,et al.  Granzyme B secretion by human memory CD4 T cells is less strictly regulated compared to memory CD8 T cells , 2014, BMC Immunology.

[19]  Bjoern Peters,et al.  Sterile Immunity to Malaria after DNA Prime/Adenovirus Boost Immunization Is Associated with Effector Memory CD8+T Cells Targeting AMA1 Class I Epitopes , 2014, PloS one.

[20]  Mario Roederer,et al.  Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine , 2013, Science.

[21]  Bjoern Peters,et al.  Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP) , 2013, Malaria Journal.

[22]  A. Cowman,et al.  The cellular and molecular basis for malaria parasite invasion of the human red blood cell , 2012, The Journal of cell biology.

[23]  Jinn-Moon Yang,et al.  Steric recognition of T‐cell receptor contact residues is required to map mutant epitopes by immunoinformatical programmes , 2012, Immunology.

[24]  W. Weiss,et al.  Protective CD8+ T lymphocytes in Primates Immunized with Malaria Sporozoites , 2012, PloS one.

[25]  R. Sauerwein,et al.  Longevity and Composition of Cellular Immune Responses Following Experimental Plasmodium falciparum Malaria Infection in Humans , 2011, PLoS pathogens.

[26]  Photini Sinnis,et al.  The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host , 2011, The Journal of experimental medicine.

[27]  Bjoern Peters,et al.  Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein , 2010, Malaria Journal.

[28]  P. de la Vega,et al.  Immunization with Pre-Erythrocytic Antigen CelTOS from Plasmodium falciparum Elicits Cross-Species Protection against Heterologous Challenge with Plasmodium berghei , 2010, PloS one.

[29]  T. Richie,et al.  The RTS,S malaria vaccine. , 2010, Vaccine.

[30]  Kimberly R. Jordan,et al.  Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens , 2010, Proceedings of the National Academy of Sciences.

[31]  J. Mullins,et al.  Functional properties and epitope characteristics of T-cells recognizing natural HIV-1 variants. , 2009, Vaccine.

[32]  S. Kappe,et al.  Genetically Attenuated Parasite Vaccines Induce Contact-Dependent CD8+ T Cell Killing of Plasmodium yoelii Liver Stage-Infected Hepatocytes1 , 2009, The Journal of Immunology.

[33]  M. Demoitié,et al.  Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. , 2008, The New England journal of medicine.

[34]  Bjoern Peters,et al.  HLA class I supertypes: a revised and updated classification , 2008, BMC Immunology.

[35]  Inacio Mandomando,et al.  Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial , 2004, The Lancet.

[36]  Markus S. Mueller,et al.  A Role for Apical Membrane Antigen 1 during Invasion of Hepatocytes by Plasmodium falciparum Sporozoites* , 2004, Journal of Biological Chemistry.

[37]  John Sidney,et al.  Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Schmidt,et al.  A Modified Hepatitis B Virus Core Particle Containing Multiple Epitopes of the Plasmodium falciparum Circumsporozoite Protein Provides a Highly Immunogenic Malaria Vaccine in Preclinical Analyses in Rodent and Primate Hosts , 2002, Infection and Immunity.

[39]  Denis Hochstrasser,et al.  A Totally Synthetic Polyoxime Malaria Vaccine Containing Plasmodium falciparum B Cell and Universal T Cell Epitopes Elicits Immune Responses in Volunteers of Diverse HLA Types1 , 2001, The Journal of Immunology.

[40]  T. McCutchan,et al.  The Cytotoxic T-Lymphocyte Epitope of the Plasmodium falciparum Circumsporozoite Protein Also Modulates the Efficiency of Receptor-Ligand Interaction with Hepatocytes , 2000, Infection and Immunity.

[41]  S. Hoffman,et al.  Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. , 1998, Science.

[42]  C DeLisi,et al.  Structural principles that govern the peptide-binding motifs of class I MHC molecules. , 1998, Journal of molecular biology.

[43]  A. Hill,et al.  Immune evasion in malaria: altered peptide ligands of the circumsporozoite protein , 1997, Parasitology.

[44]  A. Hill,et al.  A protein particle vaccine containing multiple malaria epitopes , 1997, Nature Biotechnology.

[45]  Andrea Crisanti,et al.  TRAP Is Necessary for Gliding Motility and Infectivity of Plasmodium Sporozoites , 1997, Cell.

[46]  R W Chesnut,et al.  Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. , 1997, Immunity.

[47]  M. Aidoo,et al.  Cytotoxic T lymphocytes to Plasmodium falciparum epitopes in an area of intense and perennial transmission in Tanzania , 1996, European journal of immunology.

[48]  R. Zinkernagel,et al.  Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. , 1996, Annual review of immunology.

[49]  S. Hoffman,et al.  Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2 , 1995, The Journal of experimental medicine.

[50]  J. Sadoff,et al.  Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. , 1995, The Journal of infectious diseases.

[51]  A. Hill,et al.  Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria , 1995, The Lancet.

[52]  H Hengartner,et al.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. , 1994, Science.

[53]  O. Doumbo,et al.  Analysis of the human antibody response to thrombospondin-related anonymous protein of Plasmodium falciparum , 1993, Infection and immunity.

[54]  M. Aidoo,et al.  Molecular analysis of the association of HLA-B53 and resistance to severe malaria , 1992, Nature.

[55]  V. Nussenzweig,et al.  Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. , 1987, Journal of immunology.